Skip to content

Catalio Capital Management, LP

Follow

13F filer, CIK 1958125, NEW YORK, NY

Catalio Capital Management, LP reported $538,308,196 across 47 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 48.44% of the portfolio.

Accepted , ingested 13F-HR 0001958125-26-000012

Period
2026-09-30
Reported value
$538M
Holdings
47
Top 10 weight
48.44%
New
14
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ARWRnew+315,247$20.6M
CELCnew+230,609$18.3M
GHnew+92,579$16.5M
ASNDadded+69,686$15.9M
TXGnew+164,029$14.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GILDexited-269,309-$34M
NTRAreduced-69,651-$28.8M
HTFLreduced-508,086-$25.3M
INCYexited-191,627-$21.7M
AXSMexited-43,182-$10.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001958125-26-000012, largest first. % of portfolio is the value over $538,308,196, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,675,830 shares; 2026Q3: 1,698,851 shares 1,698,851$48.4M8.99%+23,021Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 499,151 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 647,899 shares; 2026Q1: 420,727 shares; 2026Q2: 412,961 shares; 2026Q3: 499,716 shares 499,716$31.2M5.79%+86,755Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 898,458 shares; 2025Q1: 962,883 shares; 2025Q2: 927,711 shares; 2025Q3: 622,729 shares; 2025Q4: 410,700 shares; 2026Q1: 432,014 shares; 2026Q2: 455,041 shares; 2026Q3: 425,111 shares 425,111$28M5.2%-29,930Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 824,043 shares; 2026Q3: 824,043 shares 824,043$26.6M4.94%0Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 120,840 shares; 2026Q1: not reported; 2026Q2: 138,946 shares; 2026Q3: 99,496 shares 99,496$26.3M4.89%-39,450Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 31,759 shares; 2026Q3: 101,445 shares 101,445$23.1M4.29%+69,686Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 315,247 shares 315,247$20.6M3.83%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,733,701 shares; 2025Q2: 2,104,512 shares; 2025Q3: 1,614,717 shares; 2025Q4: 1,196,807 shares; 2026Q1: 1,043,670 shares; 2026Q2: 1,215,698 shares; 2026Q3: 1,023,510 shares 1,023,510$19.2M3.57%-192,188Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,037,984 shares; 2026Q2: 562,672 shares; 2026Q3: 497,964 shares 497,964$19M3.52%-64,708Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 230,609 shares 230,609$18.3M3.41%newTimeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,024,245 shares; 2025Q1: 1,024,245 shares; 2025Q2: 294,360 shares; 2025Q3: 294,360 shares; 2025Q4: 294,360 shares; 2026Q1: 294,360 shares; 2026Q2: 536,152 shares; 2026Q3: 454,015 shares 454,015$17.8M3.3%-82,137Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 92,579 shares 92,579$16.5M3.07%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 106,799 shares; 2026Q3: 112,418 shares 112,418$15.8M2.94%+5,619Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 164,029 shares 164,029$14.8M2.75%newTimeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 505,882 shares 505,882$14.7M2.73%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 331,849 shares; 2026Q1: 439,041 shares; 2026Q2: 648,722 shares; 2026Q3: 583,364 shares 583,364$14.7M2.72%-65,358Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 333,144 shares; 2025Q1: 435,588 shares; 2025Q2: 390,932 shares; 2025Q3: not reported; 2025Q4: 187,048 shares; 2026Q1: 144,607 shares; 2026Q2: 124,778 shares; 2026Q3: 161,121 shares 161,121$13.9M2.58%+36,343Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 891,933 shares; 2026Q2: 1,080,888 shares; 2026Q3: 1,021,499 shares 1,021,499$11.8M2.19%-59,389Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 173,582 shares; 2026Q2: 45,856 shares; 2026Q3: 95,646 shares 95,646$11.6M2.15%+49,790Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,921,568 shares 3,921,568$11.4M2.12%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 179,815 shares; 2025Q1: not reported; 2025Q2: 30,661 shares; 2025Q3: 216,527 shares; 2025Q4: 110,427 shares; 2026Q1: 122,978 shares; 2026Q2: 159,384 shares; 2026Q3: 172,709 shares 172,709$11.3M2.1%+13,325Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 457,839 shares; 2026Q3: 457,839 shares 457,839$10.2M1.89%0Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 471,254 shares; 2026Q3: 684,753 shares 684,753$9.8M1.82%+213,499Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 213,402 shares; 2025Q3: 291,262 shares; 2025Q4: 162,550 shares; 2026Q1: 850,797 shares; 2026Q2: 316,252 shares; 2026Q3: 601,760 shares 601,760$9.04M1.68%+285,508Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 144,971 shares 144,971$8.7M1.62%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,986,806 shares 1,986,806$8.4M1.56%newTimeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 85,614 shares 85,614$8.15M1.51%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 569,395 shares; 2025Q1: 704,864 shares; 2025Q2: 670,575 shares; 2025Q3: 651,810 shares; 2025Q4: 252,901 shares; 2026Q1: 255,379 shares; 2026Q2: 276,550 shares; 2026Q3: 260,109 shares 260,109$8.13M1.51%-16,441Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 126,817 shares 126,817$7.68M1.43%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 84,352 shares; 2026Q2: 148,045 shares; 2026Q3: 211,985 shares 211,985$6.42M1.19%+63,940Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 167,716 shares 167,716$5.37M1%newTimeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 468,750 shares; 2026Q3: 468,750 shares 468,750$5.35M0.99%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 97,297 shares; 2025Q3: 148,369 shares; 2025Q4: 62,273 shares; 2026Q1: 70,907 shares; 2026Q2: 82,181 shares; 2026Q3: 12,530 shares 12,530$5.18M0.96%-69,651Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 214,236 shares; 2025Q1: 214,236 shares; 2025Q2: 214,236 shares; 2025Q3: 5,214,236 shares; 2025Q4: 5,491,866 shares; 2026Q1: 5,491,866 shares; 2026Q2: 6,168,749 shares; 2026Q3: 8,841,707 shares 8,841,707$4.81M0.89%+2,672,958Timeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 312,500 shares; 2026Q3: 312,500 shares 312,500$4.61M0.86%0Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,061,132 shares; 2025Q4: 1,259,820 shares; 2026Q1: 1,639,816 shares; 2026Q2: 1,695,071 shares; 2026Q3: 1,637,114 shares 1,637,114$4.14M0.77%-57,957Timeline
HTFLHEARTFLOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 113,857 shares; 2026Q1: 403,588 shares; 2026Q2: 583,055 shares; 2026Q3: 74,969 shares 74,969$3.73M0.69%-508,086Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 318,407 shares; 2026Q3: 699,532 shares 699,532$2.87M0.53%+381,125Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 87,702 shares 87,702$2.81M0.52%newTimeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 158,170 shares 158,170$2.49M0.46%newTimeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,088,691 shares; 2025Q1: 1,088,691 shares; 2025Q2: 1,626,370 shares; 2025Q3: 1,500,793 shares; 2025Q4: 1,446,254 shares; 2026Q1: 580,024 shares; 2026Q2: 520,148 shares; 2026Q3: 512,287 shares 512,287$1.56M0.29%-7,861Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 155,622 shares; 2025Q2: 146,013 shares; 2025Q3: 142,984 shares; 2025Q4: 142,984 shares; 2026Q1: 897,709 shares; 2026Q2: 940,855 shares; 2026Q3: 976,191 shares 976,191$1.19M0.22%+35,336Timeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 760,035 shares; 2025Q1: 760,035 shares; 2025Q2: 760,035 shares; 2025Q3: 684,541 shares; 2025Q4: 1,320,041 shares; 2026Q1: 1,320,041 shares; 2026Q2: 1,320,041 shares; 2026Q3: 1,303,155 shares 1,303,155$1.05M0.2%-16,886Timeline
MGXMETAGENOMI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 528,993 shares; 2025Q1: 528,993 shares; 2025Q2: 528,993 shares; 2025Q3: 528,993 shares; 2025Q4: 528,993 shares; 2026Q1: 528,993 shares; 2026Q2: 528,993 shares; 2026Q3: 528,993 shares 528,993$561K0.1%0Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,718 shares; 2025Q3: 14,718 shares; 2025Q4: 14,718 shares; 2026Q1: 14,718 shares; 2026Q2: 14,718 shares; 2026Q3: 14,718 shares 14,718$438K0.08%0Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 166,666 shares; 2025Q2: 166,666 shares; 2025Q3: 118,279 shares; 2025Q4: 118,279 shares; 2026Q1: 118,279 shares; 2026Q2: 118,279 shares; 2026Q3: 107,456 shares 107,456$322K0.06%-10,823Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 11,357 shares 11,357$226K0.04%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GILDGILEAD SCIENCES INC269,309$34Mshares
INCYINCYTE CORP191,627$21.7Mshares
AXSMAXSOME THERAPEUTICS INC.43,182$10.6Mshares
DYNDYNE THERAPEUTICS INC244,929$5.44Mshares
DNTHDIANTHUS THERAPEUTICS INC32,941$3.21Mshares
ATAIATAIBECKLEY INC196,858$1.04Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001958125-26-000012 base2026-11-16